Bio-Techne Corporation (TECH) Institutional Ownership & Insider Trading

596 institutions reported holding Bio-Techne Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TECHBio-Techne CorporationFollow TECH — free

Biotechnology · Healthcare

—

Price chart with a free account

Market cap: 11.4B
P/E TTM: 63.1
Dividend yield: 0.4%
52-week: —
Next earnings: 3 Nov, in 10 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

596 institutions held —% of the shares. Across filers that reported both quarters, shares held changed -2.1%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	596	175	-2.1%	147	113	222	92
Mar 26	579	177	+4.5%	176	46	200	49
Dec 25	575	171	+5.3%	190	57	180	58
Sep 25	559	160	+1.4%	193	75	162	49
Jun 25	546	159	-2.6%	199	62	168	82
Mar 25	563	160	+0.1%	177	62	181	55
Dec 24	562	159	+2.2%	191	37	166	41
Sep 24	547	153	-3.3%	163	44	172	48

Bio-Techne Corporation — questions

Who owns Bio-Techne Corporation stock?: 596 institutions reported Bio-Techne Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.9%), FMR LLC (8.2%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%).
Are Bio-Techne Corporation insiders buying or selling?: 2 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Bio-Techne Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.